Total anomalous pulmonary venous connection medical therapy

Total anomalous pulmonary venous connection Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Total anomalous pulmonary venous connection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
MRI
CT
Echocardiography
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Case Studies
Case #1
Total anomalous pulmonary venous connection medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Total anomalous pulmonary venous connection medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Total anomalous pulmonary venous connection medical therapy
CDC on Total anomalous pulmonary venous connection medical therapy
Total anomalous pulmonary venous connection medical therapy in the news
Blogs on Total anomalous pulmonary venous connection medical therapy
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Total anomalous pulmonary venous connection medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief:Cafer Zorkun, M.D., Ph.D. [2]; Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [[4]]

Assistant Editor-In-Chief: Kristin Feeney, B.S. [[5]]

Overview

Medical therapy are primarily used to stabilize the patient of total anomalous pulmonary venous connection

Medical therapy

Prior to surgery the patients have to be stabilized. It may be achieved by-

• Giving respiratory support by supplemental oxygen, mechanical ventilation, extracorporeal membrane oxygenation
• Inotropic support in progressive heart failure .
• High ceiling diuretics like furesemide to help treating pulmonary edema
• Prostaglandin therapy to keep the ductus patent.
• Palliative angiography can be used to create atrial septostomy in severely obstructed total anomalous pulmonary venous connection.

Patients with unobstructed TAPVC who present after the immediate newborn period with signs of pulmonary overcirculation may benefit from diuretic therapy. We generally use furosemide at an oral dose of 1 to 2 mg/kg given twice a day.